Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2018 Financial Results
22 août 2018 22h10 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and twelve months ended June 30, 2018....
Novoheart Appoints Biotech Industry Specialist as New Senior Vice President to Lead Commercial Development
01 août 2018 03h05 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, announced today that it has...
Novoheart Announces Presentation at the International Society for Stem Cell Research Annual Meeting
25 juin 2018 03h05 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH) is pleased to announce a presentation was delivered on June 22nd, 2018,...
Novoheart Wins Coveted 2018 MedTech Breakthrough Award
13 juin 2018 03h00 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that its...
Novoheart Receives C$400,000 in Research Funding from the Innovation and Technology Commission of Hong Kong
06 juin 2018 05h20 HE
|
Novoheart Holdings Inc.
HONG KONG, June 06, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, is pleased to announce that its wholly owned...
Novoheart Becomes Member of International Consortium Advancing Cardiac Safety in Drug Development
31 mai 2018 03h00 HE
|
Novoheart Holdings Inc.
Participation positions the Company to help define future industry and regulatory standards for effective cardiotoxicity screening of all newly developed drugs VANCOUVER, British Columbia, May 31,...
Novoheart Holdings Inc. Reports Third Quarter 2018 Financial Results
11 mai 2018 19h20 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, May 11, 2018 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and nine months ended March 31, 2018....
Novoheart to Debut New, State-of-the-art ‘Human Heart-in-a-Jar 2.0’ Technology at the 2018 International Society for Stem Cell Research (ISSCR) Annual Meeting
02 mai 2018 03h05 HE
|
Novoheart Holdings Inc.
ISSCR Meeting in Melbourne to host over 4,000 attendees including notable scientists, innovators, industry representatives and mediaNovoheart’s proprietary ‘Human heart-in-a-jar 2.0’ now enhanced with...
Novoheart Founder & CEO Dr. Ronald Li honored with 2017 Distinguished Alumnus Award by the University of Waterloo
12 avr. 2018 03h05 HE
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, April 12, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH) is pleased to announce that Dr. Ronald Li, Founder and CEO of the...
Novoheart Announces Successful Completion of Second Commercial Contract with Global Pharmaceutical Company
30 janv. 2018 07h30 HE
|
Novoheart Holdings Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2018) - Novoheart ("Novoheart" or the "Company") (TSX VENTURE:NVH) is pleased to announce the successful completion of a second...